Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway

Abstract Transient receptor potential vanilloid 4 (TRPV4) plays an important role in chondrocytes via Ca2+ signaling. However, its role in the progression of osteoarthritis is unclear. This study aimed to evaluate the effects of TRPV4 activation on articular cartilage and chondrocytes stimulated wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kyosuke Hattori, Nobunori Takahashi, Kenya Terabe, Yoshifumi Ohashi, Kenji Kishimoto, Yutaka Yokota, Mochihito Suzuki, Toshihisa Kojima, Shiro Imagama
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/231ecfd498d84543b2e0b82fc0db45a9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:231ecfd498d84543b2e0b82fc0db45a9
record_format dspace
spelling oai:doaj.org-article:231ecfd498d84543b2e0b82fc0db45a92021-12-02T18:47:00ZActivation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway10.1038/s41598-021-94938-32045-2322https://doaj.org/article/231ecfd498d84543b2e0b82fc0db45a92021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94938-3https://doaj.org/toc/2045-2322Abstract Transient receptor potential vanilloid 4 (TRPV4) plays an important role in chondrocytes via Ca2+ signaling. However, its role in the progression of osteoarthritis is unclear. This study aimed to evaluate the effects of TRPV4 activation on articular cartilage and chondrocytes stimulated with interleukin (IL)-1β. Bovine and human articular chondrocytes were stimulated with various agents, including IL-1β, GSK1016790A (GSK101; a TRPV4 agonist), Compound C (an AMP-activated protein kinase (AMPK) inhibitor), and STO-609 (a calmodulin-dependent protein kinase kinase (CaMKK) inhibitor), and were processed for Western blot analysis and real-time PCR. The dimethylmethylene blue (DMMB) assay and Safranin O staining were also performed. GSK101 reversed the IL-1β-induced increase in expression of matrix metalloproteinase (MMP)-13 and decrease in expression of aggrecan. GSK101 also decreased proteoglycan release in the DMMB assay and retained Safranin O staining of articular cartilage tissue. Furthermore, GSK101 increased AMPK phosphorylation and decreased IL-1β-induced nuclear factor kappa B (NF-κB) phosphorylation. Compound C and STO-609 reversed the suppressive effects of GSK101 on NF-κB activation and MMP-13 expression. In conclusion, TRPV4 activation had chondroprotective effects on articular cartilage stimulated with IL-1β by activating CaMKK/AMPK and suppressing the NF-κB pathway. TRPV4 activators may offer a promising therapeutic option for preventing the progression of osteoarthritis.Kyosuke HattoriNobunori TakahashiKenya TerabeYoshifumi OhashiKenji KishimotoYutaka YokotaMochihito SuzukiToshihisa KojimaShiro ImagamaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kyosuke Hattori
Nobunori Takahashi
Kenya Terabe
Yoshifumi Ohashi
Kenji Kishimoto
Yutaka Yokota
Mochihito Suzuki
Toshihisa Kojima
Shiro Imagama
Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway
description Abstract Transient receptor potential vanilloid 4 (TRPV4) plays an important role in chondrocytes via Ca2+ signaling. However, its role in the progression of osteoarthritis is unclear. This study aimed to evaluate the effects of TRPV4 activation on articular cartilage and chondrocytes stimulated with interleukin (IL)-1β. Bovine and human articular chondrocytes were stimulated with various agents, including IL-1β, GSK1016790A (GSK101; a TRPV4 agonist), Compound C (an AMP-activated protein kinase (AMPK) inhibitor), and STO-609 (a calmodulin-dependent protein kinase kinase (CaMKK) inhibitor), and were processed for Western blot analysis and real-time PCR. The dimethylmethylene blue (DMMB) assay and Safranin O staining were also performed. GSK101 reversed the IL-1β-induced increase in expression of matrix metalloproteinase (MMP)-13 and decrease in expression of aggrecan. GSK101 also decreased proteoglycan release in the DMMB assay and retained Safranin O staining of articular cartilage tissue. Furthermore, GSK101 increased AMPK phosphorylation and decreased IL-1β-induced nuclear factor kappa B (NF-κB) phosphorylation. Compound C and STO-609 reversed the suppressive effects of GSK101 on NF-κB activation and MMP-13 expression. In conclusion, TRPV4 activation had chondroprotective effects on articular cartilage stimulated with IL-1β by activating CaMKK/AMPK and suppressing the NF-κB pathway. TRPV4 activators may offer a promising therapeutic option for preventing the progression of osteoarthritis.
format article
author Kyosuke Hattori
Nobunori Takahashi
Kenya Terabe
Yoshifumi Ohashi
Kenji Kishimoto
Yutaka Yokota
Mochihito Suzuki
Toshihisa Kojima
Shiro Imagama
author_facet Kyosuke Hattori
Nobunori Takahashi
Kenya Terabe
Yoshifumi Ohashi
Kenji Kishimoto
Yutaka Yokota
Mochihito Suzuki
Toshihisa Kojima
Shiro Imagama
author_sort Kyosuke Hattori
title Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway
title_short Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway
title_full Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway
title_fullStr Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway
title_full_unstemmed Activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via CaMKK/AMPK/NF-κB signaling pathway
title_sort activation of transient receptor potential vanilloid 4 protects articular cartilage against inflammatory responses via camkk/ampk/nf-κb signaling pathway
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/231ecfd498d84543b2e0b82fc0db45a9
work_keys_str_mv AT kyosukehattori activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT nobunoritakahashi activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT kenyaterabe activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT yoshifumiohashi activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT kenjikishimoto activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT yutakayokota activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT mochihitosuzuki activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT toshihisakojima activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
AT shiroimagama activationoftransientreceptorpotentialvanilloid4protectsarticularcartilageagainstinflammatoryresponsesviacamkkampknfkbsignalingpathway
_version_ 1718377668654661632